Literature DB >> 12573868

The effect of apomorphine administration on smooth pursuit ocular movements in early Parkinsonian patients.

Martin Bares1, Milan Brázdil, Petr Kanovský, Pavel Jurák, Pavel Daniel, Miloslav Kukleta, Ivan Rektor.   

Abstract

Electrooculography (EOG) recordings in 21 L-DOPA-naive patients suffering from Parkinson's disease (PD) were made before and after apomorphine subcutaneous administration (ASA). The effect of apomorphine on smooth pursuit eye movements (SPEM) was studied. Age-matched healthy subjects, who underwent SPEM recordings without the ASA procedure, were examined in order to compare baseline SPEM. EOG recordings were used to compare the patient group and the control group, and to compare the SPEM before and after ASA within the patient group. Significant differences in SPEM were found between both groups, as well as in the SPEM before and after ASA. The theory that SPEM is disturbed in early PD patients was confirmed. The dopaminergic control of horizontal SPEM is supposed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12573868     DOI: 10.1016/s1353-8020(02)00015-9

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  17 in total

1.  Visual exploration of emotional facial expressions in Parkinson's disease.

Authors:  Uraina S Clark; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychologia       Date:  2010-03-15       Impact factor: 3.139

2.  In Six-month-old Infants, Prenatal Exposure to Maternal Anxiety is Associated with Less Developed Smooth Pursuit Eye Movements: An Initial Study.

Authors:  Laurel Pellegrino; Randal G Ross; Sharon K Hunter
Journal:  Int Neuropsychiatr Dis J       Date:  2013

3.  Impaired oculomotor function in a community-based patient population with newly diagnosed idiopathic parkinsonism.

Authors:  Jan Linder; Britt-Inger Wenngren; Hans Stenlund; Lars Forsgren
Journal:  J Neurol       Date:  2011-12-16       Impact factor: 4.849

Review 4.  Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.

Authors:  Dirk Deleu; Yolande Hanssens; Margaret G Northway
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  The effect of L-Dopa administration on pursuit ocular movements in suspected Parkinson's disease.

Authors:  Silvia Marino; Pietro Lanzafame; Edoardo Sessa; Alessia Bramanti; Placido Bramanti
Journal:  Neurol Sci       Date:  2009-11-19       Impact factor: 3.307

6.  Predictive motor timing performance dissociates between early diseases of the cerebellum and Parkinson's disease.

Authors:  Martin Bares; Ovidiu V Lungu; Ivica Husárová; Tomás Gescheidt
Journal:  Cerebellum       Date:  2010-03       Impact factor: 3.847

7.  Visual scan paths in first-episode schizophrenia and cannabis-induced psychosis.

Authors:  Philip J Benson; Ute Leonards; Robert M Lothian; David M St Clair; Marco C G Merlo
Journal:  J Psychiatry Neurosci       Date:  2007-07       Impact factor: 6.186

Review 8.  Treatment of Visual Disorders in Parkinson Disease.

Authors:  Joseph Savitt; Michaela Mathews
Journal:  Curr Treat Options Neurol       Date:  2018-06-23       Impact factor: 3.598

Review 9.  Pharmacological treatment effects on eye movement control.

Authors:  James L Reilly; Rebekka Lencer; Jeffrey R Bishop; Sarah Keedy; John A Sweeney
Journal:  Brain Cogn       Date:  2008-12       Impact factor: 2.310

10.  Subthalamic deep brain stimulation improves smooth pursuit and saccade performance in patients with Parkinson's disease.

Authors:  Maria H Nilsson; Mitesh Patel; Stig Rehncrona; Måns Magnusson; Per-Anders Fransson
Journal:  J Neuroeng Rehabil       Date:  2013-04-03       Impact factor: 4.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.